Tapewire

NYSE · USD

BR

BROADRIDGE FINANCIAL SOLUTIONS, INC.

Export transactions ↓
Tapewire entity
3252
SEC CIK
0001383312
Parsed reports
1,212

Last 12 months

Inside the activity.

1 purchase rows · 8 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202602
Mar 202610
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantCommon Stock 458 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009963 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,158

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC
keller brettDirector
GrantStock Option (Right to Buy) · Derivative 1,844 $0.00 Strike: $227.56 $0.00
Disclosure

SEC source: 0001225208-24-009964 · doc4.xml · derivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,844

Underlying: Common Stock · 1,844 shares

Expires 2034-11-14

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC
keller brettDirector
GrantCommon Stock 458 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009964 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,940

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantStock Option (Right to Buy) · Derivative 2,467 $0.00 Strike: $227.56 $0.00
Disclosure

SEC source: 0001225208-24-009966 · doc4.xml · derivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,467

Underlying: Common Stock · 2,467 shares

Expires 2034-11-14

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantCommon Stock 613 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009966 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,950

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC
Zavery AmitDirector
GrantStock Option (Right to Buy) · Derivative 1,844 $0.00 Strike: $227.56 $0.00
Disclosure

SEC source: 0001225208-24-009968 · doc4.xml · derivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,844

Underlying: Common Stock · 1,844 shares

Expires 2034-11-14

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC
Zavery AmitDirector
GrantCommon Stock 458 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009968 · doc4.xml · nonDerivative · entry 1

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,255

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantStock Option (Right to Buy) · Derivative 1,844 $0.00 Strike: $227.56 $0.00
Disclosure

SEC source: 0001225208-24-009967 · doc4.xml · derivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,844

Underlying: Common Stock · 1,844 shares

Expires 2034-11-14

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantCommon Stock 458 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009967 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,943

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantStock Option (Right to Buy) · Derivative 1,844 $0.00 Strike: $227.56 $0.00
Disclosure

SEC source: 0001225208-24-009965 · doc4.xml · derivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,844

Underlying: Common Stock · 1,844 shares

Expires 2034-11-14

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantCommon Stock 458 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009965 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,246.102

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantStock Option (Right to Buy) · Derivative 1,844 $0.00 Strike: $227.56 $0.00
Disclosure

SEC source: 0001225208-24-009961 · doc4.xml · derivative · entry 2

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,844

Underlying: Common Stock · 1,844 shares

Expires 2034-11-14

F2 · derivative.exercise_date: Stock options vest immediately upon grant.

Read SEC document
November 14, 2024 Filed Nov 15, 2024 19:32 UTC GrantCommon Stock 458 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009961 · doc4.xml · nonDerivative · entry 1

Carter Pamela L · CIK 0001396958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,126

F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
November 12, 2024 Filed Nov 12, 2024 15:47 UTC
Matlin LauraCVP, Deputy GC and CCO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,888 $0.00 Strike: $98.31 $0.00
Disclosure

SEC source: 0001225208-24-009864 · doc4.xml · derivative · entry 6

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,888 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2024 Filed Nov 12, 2024 15:47 UTC
Matlin LauraCVP, Deputy GC and CCO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,920 $0.00 Strike: $117.34 $0.00
Disclosure

SEC source: 0001225208-24-009864 · doc4.xml · derivative · entry 5

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,920 shares

Expires 2030-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2024 Filed Nov 12, 2024 15:47 UTC
Matlin LauraCVP, Deputy GC and CCO
SaleCommon Stock 3,459 $227.65 $787,456.22
Disclosure

SEC source: 0001225208-24-009864 · doc4.xml · nonDerivative · entry 4

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,115.696

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.190 - $227.955, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 12, 2024 Filed Nov 12, 2024 15:47 UTC
Matlin LauraCVP, Deputy GC and CCO
SaleCommon Stock 3,351 $227.65 $762,869.56
Disclosure

SEC source: 0001225208-24-009864 · doc4.xml · nonDerivative · entry 3

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,574.696

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.190 - $227.955, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 12, 2024 Filed Nov 12, 2024 15:47 UTC
Matlin LauraCVP, Deputy GC and CCO
Exercise / conversionCommon Stock 3,888 $98.31 $382,229.28
Disclosure

SEC source: 0001225208-24-009864 · doc4.xml · nonDerivative · entry 2

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,925.696

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2024 Filed Nov 12, 2024 15:47 UTC
Matlin LauraCVP, Deputy GC and CCO
Exercise / conversionCommon Stock 3,920 $117.34 $459,972.80
Disclosure

SEC source: 0001225208-24-009864 · doc4.xml · nonDerivative · entry 1

Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,037.696

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,180 $0.00 Strike: $173.00 $0.00
Disclosure

SEC source: 0001225208-24-009847 · doc4.xml · derivative · entry 6

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,180

Underlying: Common Stock · 1,180 shares

Expires 2031-11-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,120 $0.00 Strike: $176.18 $0.00
Disclosure

SEC source: 0001225208-24-009847 · doc4.xml · derivative · entry 5

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,121

Underlying: Common Stock · 1,120 shares

Expires 2033-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 1,365 $0.00 Strike: $133.74 $0.00
Disclosure

SEC source: 0001225208-24-009847 · doc4.xml · derivative · entry 4

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,365

Underlying: Common Stock · 1,365 shares

Expires 2032-11-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC Exercise / conversionCommon Stock 1,120 $176.18 $197,321.60
Disclosure

SEC source: 0001225208-24-009847 · doc4.xml · nonDerivative · entry 3

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC Exercise / conversionCommon Stock 1,180 $173.00 $204,140.00
Disclosure

SEC source: 0001225208-24-009847 · doc4.xml · nonDerivative · entry 2

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC Exercise / conversionCommon Stock 1,365 $133.74 $182,555.10
Disclosure

SEC source: 0001225208-24-009847 · doc4.xml · nonDerivative · entry 1

Nazareth Annette L. · CIK 0001846828 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 6,469 $0.00 Strike: $45.09 $0.00
Disclosure

SEC source: 0001225208-24-009846 · doc4.xml · derivative · entry 3

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,469 shares

Expires 2024-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC SaleCommon Stock 3,880 $227.02 $880,835.66
Disclosure

SEC source: 0001225208-24-009846 · doc4.xml · nonDerivative · entry 2

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,788.102

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.86 - $227.155, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC Exercise / conversionCommon Stock 6,469 $45.09 $291,687.21
Disclosure

SEC source: 0001225208-24-009846 · doc4.xml · nonDerivative · entry 1

Markus Maura A. · CIK 0001571545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,668.102

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 5,969 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-24-009845 · doc4.xml · derivative · entry 7

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,163

Underlying: Common Stock · 5,969 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC
Carey Thomas PCorporate VP
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $93.88 $0.00
Disclosure

SEC source: 0001225208-24-009845 · doc4.xml · derivative · entry 6

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,132

Underlying: Common Stock · 3,000 shares

Expires 2028-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 5,045 $226.82 $1,144,286.72
Disclosure

SEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 5

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,689

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.52 - $227.30, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 3,177 $226.82 $720,594.43
Disclosure

SEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 4

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,734

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.52 - $227.30, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC
Carey Thomas PCorporate VP
SaleCommon Stock 2,535 $226.82 $574,978.56
Disclosure

SEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 3

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,911

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.52 - $227.30, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC
Carey Thomas PCorporate VP
Exercise / conversionCommon Stock 3,000 $93.88 $281,640.00
Disclosure

SEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 2

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2024 Filed Nov 12, 2024 17:49 UTC
Carey Thomas PCorporate VP
Exercise / conversionCommon Stock 5,969 $93.88 $560,369.72
Disclosure

SEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 1

Carey Thomas P · CIK 0001731499 · Corporate VP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 17:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 8,999 $0.00 Strike: $67.32 $0.00
Disclosure

SEC source: 0001225208-24-009795 · doc4.xml · derivative · entry 7

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,999 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 17:30 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 8,764 $0.00 Strike: $51.95 $0.00
Disclosure

SEC source: 0001225208-24-009795 · doc4.xml · derivative · entry 6

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,764 shares

Expires 2026-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 17:30 UTC SaleCommon Stock 9,571 $220.21 $2,107,645.22
Disclosure

SEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 5

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,136.8948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.54 - $221.24, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 17:30 UTC SaleCommon Stock 7,481 $220.21 $1,647,402.98
Disclosure

SEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 4

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,707.8948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.54 - $221.24, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 17:30 UTC SaleCommon Stock 7,133 $220.21 $1,570,769.34
Disclosure

SEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 3

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,188.8948

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.54 - $221.24, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 17:30 UTC Exercise / conversionCommon Stock 8,764 $51.95 $455,289.80
Disclosure

SEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 2

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,321.8948

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2024 Filed Nov 8, 2024 17:30 UTC Exercise / conversionCommon Stock 8,999 $67.32 $605,812.68
Disclosure

SEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 1

DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,557.8948

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 16:27 UTC GrantCommon Stock 80 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009199 · doc4.xml · nonDerivative · entry 1

Duelks Robert N · CIK 0001477044 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,749

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 16:27 UTC GrantCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009202 · doc4.xml · nonDerivative · entry 1

FLOWERS MELVIN L · CIK 0001196490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,700

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 16:27 UTC
keller brettDirector
GrantCommon Stock 14 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009201 · doc4.xml · nonDerivative · entry 2

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,482

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 16:27 UTC
keller brettDirector
GrantCommon Stock 32 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009201 · doc4.xml · nonDerivative · entry 1

KELLER BRETT · CIK 0001214608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,468

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 12:27 UTC GrantCommon Stock 115 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009198 · doc4.xml · nonDerivative · entry 1

BRUN LESLIE A · CIK 0001217068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,433

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 16:27 UTC GrantCommon Stock 4 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009203 · doc4.xml · nonDerivative · entry 2

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,333

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 16:27 UTC GrantCommon Stock 4 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009203 · doc4.xml · nonDerivative · entry 1

MURRAY EILEEN K · CIK 0001341752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,337

F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge.

Read SEC document
October 03, 2024 Filed Oct 7, 2024 16:27 UTC
Zavery AmitDirector
GrantCommon Stock 12 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-009206 · doc4.xml · nonDerivative · entry 2

Zavery Amit · CIK 0001781064 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,797

F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.